SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IMMULOGIC
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Paul Getman who wrote (163)4/23/1997 12:32:00 PM
From: David Bleich   of 305
 
Paul:

IMUL has one good basket, Allervax. It is about time they put all their efforts on one product and bring it through. IMO there is no doubt that they will receive FDA approval for this vaccine, because the statistics are there (from the previous trial). I do not anticipate any pharmaceutical sponsorship until IMUL finishes the next Allervax trial and shows positive results. The next study is slated for June 1997 thru August 1997, with results to be published in January 1998. Based on this timetable we should see some action on the stock in October/November 1997 as the rumors about the trial start to circulate. IMUL will be filing an IND on the cocaine vaccine this May and they have the opportunity to apply for an extension of the SBIR grant which is ~$500,000 for two years, I believe. So, we may have to wait to hear additional studies with the cocaine vaccine.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News